Tom graduated University of Brighton with a BA (Hons) degree in Broadcast Journalism, leaving as the valedictorian of the class of 2015. His final year projects and dissertation were nominated for, and won, several awards, whilst he was also the Editor-in-Chief of the university’s news site during his time at Brighton. After previously writing for a property magazine, Tom joined the Proactive team in January 2016.
Liberum analyst Yuan Low says it is still early on in graphene’s development, but he has “no doubt” over its “wonder material” status and its potential further down the line
The acquisition provides Dechra with a “strategically important presence” in Brazil, the fourth largest livestock market in the world
“We were disappointed by Mediclinic's first-half trading statement yesterday, which left us less confident in the recovery story”
Patisserie’s executive chairman and major shareholder has agreed to provide loans of up to £20mln, while the sweet treats seller is also raising £15mln from investors through a steeply-discounted share placing
As a result of the IPO, the value of Arix’s stake in LogicBio has soared to almost £23mln, including the extra investment announced today
Chairman Peter Presland will take on a more active role to free up more time for CEO João Andrade to focus on sales and business development
ReNeuron thinks CTX could be reprogrammed and used to produce new non-donor-specific cell lines, including NK and T-Cells – the cells that can be modified to attack cancer cells
The approval from French regulators means Lojuxta will soon be available in all five of the EU’s largest markets
Of course if you’ve already done so, this article probably doesn’t apply to you…
Sometimes a cheap stock is cheap for a reason, not just because it’s good value…
The Rookie Investors has still got the Fever(tree), but would he have done had he set a stop-loss?
As I venture into the world of equity trading, here’s the background to my story and where I’m at now